Medical AI leader OpenEvidence has announced the commercial launch of EvidenceGrade, a new system capability that scores and visualizes the clinical certainty of cited medical literature in real time.
The feature directly targets a dangerous AI limitation: standard models tend to gloss over differences in source quality, treating small, observational studies with the same weight as randomized, blinded, placebo-controlled trials.
Built by a cross-functional team of physicians and computer scientists, EvidenceGrade adapts the GRADE framework—the methodology underlying the World Health Organization (WHO) and Cochrane guidelines—to function at point-of-care speeds.
The technology scales across edge cases where formal medical syntheses are unavailable, extending automated, structured evidence grading to the vast majority of clinical questions that lack official guidelines.
【MORE】